Hefei Hengxin Life Science and Technology Co., Ltd.
Hefei Hengxin Life Science and Technology Co., Ltd. engages in the research and development, production, and sale of polylactic acid products in China, North America, Europe, Australia, and internationally. It offers paper and clear cups, cup lids, knives, forks, spoons, straws, stirring roads, foaming tableware, food packaging containers, packing bags, cup holders, and cup sleeves. The company w… Read more
Hefei Hengxin Life Science and Technology Co., Ltd. (301501) - Net Assets
Latest net assets as of June 2025: CN¥2.07 Billion CNY
Based on the latest financial reports, Hefei Hengxin Life Science and Technology Co., Ltd. (301501) has net assets worth CN¥2.07 Billion CNY as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.73 Billion) and total liabilities (CN¥659.01 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.07 Billion |
| % of Total Assets | 75.87% |
| Annual Growth Rate | 32.26% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4.23 |
Hefei Hengxin Life Science and Technology Co., Ltd. - Net Assets Trend (2021–2024)
This chart illustrates how Hefei Hengxin Life Science and Technology Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Hefei Hengxin Life Science and Technology Co., Ltd. (2021–2024)
The table below shows the annual net assets of Hefei Hengxin Life Science and Technology Co., Ltd. from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.12 Billion | +26.45% |
| 2023-12-31 | CN¥881.87 Million | +36.18% |
| 2022-12-31 | CN¥647.57 Million | +34.39% |
| 2021-12-31 | CN¥481.86 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Hefei Hengxin Life Science and Technology Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1641.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥581.08 Million | 55.53% |
| Other Components | CN¥465.38 Million | 44.47% |
| Total Equity | CN¥1.05 Billion | 100.00% |
Hefei Hengxin Life Science and Technology Co., Ltd. Competitors by Market Cap
The table below lists competitors of Hefei Hengxin Life Science and Technology Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Building Material
SHG:603060
|
$222.42 Million |
|
Avantel Limited
NSE:AVANTEL
|
$222.42 Million |
|
WINBO-Dongjian Automotive Technology Co. Ltd.
SHE:300978
|
$222.59 Million |
|
Rechi Precision Co Ltd
TW:4532
|
$222.59 Million |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
$222.37 Million |
|
Praram 9 Hospital Public Company Limited
BK:PR9
|
$222.26 Million |
|
Dirui Industrial Co Ltd
SHE:300396
|
$222.26 Million |
|
Malteries Franco-Belges Société Anonyme
PA:MALT
|
$222.25 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Hefei Hengxin Life Science and Technology Co., Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 821,511,480 to 1,046,467,512, a change of 224,956,031 (27.4%).
- Net income of 219,888,877 contributed positively to equity growth.
- Dividend payments of 11,403,664 reduced retained earnings.
- Other factors increased equity by 16,470,819.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥219.89 Million | +21.01% |
| Dividends Paid | CN¥11.40 Million | -1.09% |
| Other Changes | CN¥16.47 Million | +1.57% |
| Total Change | CN¥- | 27.38% |
Book Value vs Market Value Analysis
This analysis compares Hefei Hengxin Life Science and Technology Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.20x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | CN¥0.00 | CN¥39.66 | x |
| 2022-12-31 | CN¥5.49 | CN¥39.66 | x |
| 2023-12-31 | CN¥7.41 | CN¥39.66 | x |
| 2024-12-31 | CN¥9.43 | CN¥39.66 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Hefei Hengxin Life Science and Technology Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.01%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 13.79%
- • Asset Turnover: 0.80x
- • Equity Multiplier: 1.90x
- Recent ROE (21.01%) is above the historical average (18.45%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 11.17% | 0.99x | 0.00x | CN¥80.27 Million |
| 2022 | 26.74% | 14.96% | 0.90x | 1.99x | CN¥101.89 Million |
| 2023 | 26.03% | 15.01% | 0.91x | 1.91x | CN¥131.71 Million |
| 2024 | 21.01% | 13.79% | 0.80x | 1.90x | CN¥115.24 Million |
Industry Comparison
This section compares Hefei Hengxin Life Science and Technology Co., Ltd.'s net assets metrics with peer companies in the Packaging & Containers industry.
Industry Context
- Industry: Packaging & Containers
- Average net assets among peers: $1,649,691,170
- Average return on equity (ROE) among peers: 4.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Hefei Hengxin Life Science and Technology Co., Ltd. (301501) | CN¥2.07 Billion | 0.00% | 0.32x | $222.41 Million |
| Zhuhai Zhongfu Enterprise Co Ltd (000659) | $243.75 Million | -28.82% | 6.53x | $570.17 Million |
| Huangshan Novel Co Ltd (002014) | $1.41 Billion | 12.64% | 0.29x | $324.87 Million |
| Shenzhen Jinjia Color Printing Group Co Ltd (002191) | $2.61 Billion | 11.62% | 0.43x | $501.74 Million |
| Xiamen Hexing Packaging Printing Co Ltd (002228) | $3.52 Billion | 2.93% | 1.34x | $305.31 Million |
| Shenzhen Beauty Star Co Ltd (002243) | $1.62 Billion | 21.22% | 0.22x | $727.03 Million |
| Zhejiang Great Southeast Co Ltd (002263) | $507.84 Million | 4.90% | 3.19x | $652.72 Million |
| Shenzhen MYS Environmental Protection & Technology Co Ltd (002303) | $277.22 Million | 36.79% | 0.68x | $465.12 Million |
| Shandong Lipeng Co Ltd (002374) | $2.16 Billion | -31.07% | 1.25x | $410.53 Million |
| Zhejiang Zhongcheng Packing Material Co Ltd (002522) | $2.07 Billion | 6.80% | 0.73x | $525.36 Million |
| Shanghai Luxin Packing Materials Science&Technology Co Ltd (002565) | $2.06 Billion | 11.10% | 0.50x | $1.10 Billion |